
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors
Andrew Stolz, Victor J. Navarro, Paul H. Hayashi, et al.
Alimentary Pharmacology & Therapeutics (2019) Vol. 49, Iss. 9, pp. 1195-1204
Open Access | Times Cited: 64
Andrew Stolz, Victor J. Navarro, Paul H. Hayashi, et al.
Alimentary Pharmacology & Therapeutics (2019) Vol. 49, Iss. 9, pp. 1195-1204
Open Access | Times Cited: 64
Showing 1-25 of 64 citing articles:
Drug-Induced Liver Injury — Types and Phenotypes
Jay H. Hoofnagle, Einar S. Björnsson
New England Journal of Medicine (2019) Vol. 381, Iss. 3, pp. 264-273
Closed Access | Times Cited: 533
Jay H. Hoofnagle, Einar S. Björnsson
New England Journal of Medicine (2019) Vol. 381, Iss. 3, pp. 264-273
Closed Access | Times Cited: 533
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Naga Chalasani, Haripriya Maddur, Mark W. Russo, et al.
The American Journal of Gastroenterology (2021) Vol. 116, Iss. 5, pp. 878-898
Open Access | Times Cited: 267
Naga Chalasani, Haripriya Maddur, Mark W. Russo, et al.
The American Journal of Gastroenterology (2021) Vol. 116, Iss. 5, pp. 878-898
Open Access | Times Cited: 267
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Robert J. Fontana, Iris Liou, Adrian Reuben, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 1036-1065
Open Access | Times Cited: 115
Robert J. Fontana, Iris Liou, Adrian Reuben, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 1036-1065
Open Access | Times Cited: 115
The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury
Robert J. Fontana, Einar S. Björnsson, K. Rajender Reddy, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2088-2099
Open Access | Times Cited: 43
Robert J. Fontana, Einar S. Björnsson, K. Rajender Reddy, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2088-2099
Open Access | Times Cited: 43
Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia
Emily Nash, Amanda Nicoll, Nicholas Batt, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 8, pp. 953-961
Closed Access | Times Cited: 7
Emily Nash, Amanda Nicoll, Nicholas Batt, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 8, pp. 953-961
Closed Access | Times Cited: 7
Challenges in herbal‐induced liver injury identification and prevention
Dina Halegoua‐DeMarzio, Victor Navarro
Liver International (2024)
Open Access | Times Cited: 6
Dina Halegoua‐DeMarzio, Victor Navarro
Liver International (2024)
Open Access | Times Cited: 6
Recent advances in the diagnosis of drug-induced liver injury
Taqwa Ahmed, Jawad Ahmad
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 186-192
Open Access | Times Cited: 5
Taqwa Ahmed, Jawad Ahmad
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 186-192
Open Access | Times Cited: 5
Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury
Merrie Mosedale, Paul B. Watkins
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 12, pp. 6436-6461
Closed Access | Times Cited: 39
Merrie Mosedale, Paul B. Watkins
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 12, pp. 6436-6461
Closed Access | Times Cited: 39
Premature Death in Bodybuilders: What Do We Know?
James M. Smoliga, Z. Taggart Wilber, Brooks Taylor Robinson
Sports Medicine (2023)
Open Access | Times Cited: 12
James M. Smoliga, Z. Taggart Wilber, Brooks Taylor Robinson
Sports Medicine (2023)
Open Access | Times Cited: 12
Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network
Fernando Bessone, Nelia Hernández, Inmaculada Medina‐Cáliz, et al.
Clinical Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 4
Fernando Bessone, Nelia Hernández, Inmaculada Medina‐Cáliz, et al.
Clinical Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 4
Drug induced cholestatic liver diseases
Einar S. Björnsson, Harshad Devarbhavi
Hepatology (2024)
Closed Access | Times Cited: 4
Einar S. Björnsson, Harshad Devarbhavi
Hepatology (2024)
Closed Access | Times Cited: 4
Liver Histology
Billel Gasmi, David E. Kleiner
Clinics in Liver Disease (2019) Vol. 24, Iss. 1, pp. 61-74
Open Access | Times Cited: 31
Billel Gasmi, David E. Kleiner
Clinics in Liver Disease (2019) Vol. 24, Iss. 1, pp. 61-74
Open Access | Times Cited: 31
Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition
Vânia Vilas‐Boas, Eva Gijbels, Joop Jonckheer, et al.
Environment International (2019) Vol. 136, pp. 105422-105422
Open Access | Times Cited: 31
Vânia Vilas‐Boas, Eva Gijbels, Joop Jonckheer, et al.
Environment International (2019) Vol. 136, pp. 105422-105422
Open Access | Times Cited: 31
Relative safety and quality of various dietary supplement products U.S. Service Members ask about
Cindy Crawford, Abraham R. Walter, Bharathi Avula, et al.
Clinical Toxicology (2022) Vol. 60, Iss. 6, pp. 737-744
Closed Access | Times Cited: 19
Cindy Crawford, Abraham R. Walter, Bharathi Avula, et al.
Clinical Toxicology (2022) Vol. 60, Iss. 6, pp. 737-744
Closed Access | Times Cited: 19
Clinical Considerations of Drug-Induced Hepatotoxicity
Melanie Hundt, Mahmoud Galal Moawad Mohamed, Lily Dara
Elsevier eBooks (2025)
Closed Access
Melanie Hundt, Mahmoud Galal Moawad Mohamed, Lily Dara
Elsevier eBooks (2025)
Closed Access
Body Building and Aminotransferase Elevations: A Review
Jaimy Villavicencio Kim, George Y. Wu
Journal of Clinical and Translational Hepatology (2020) Vol. 8, Iss. 2, pp. 161-167
Open Access | Times Cited: 22
Jaimy Villavicencio Kim, George Y. Wu
Journal of Clinical and Translational Hepatology (2020) Vol. 8, Iss. 2, pp. 161-167
Open Access | Times Cited: 22
Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature
Taylor A. Ault, David R. Braxton, Rebecca A. Watson, et al.
Journal of Medical Case Reports (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Taylor A. Ault, David R. Braxton, Rebecca A. Watson, et al.
Journal of Medical Case Reports (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 8
The Use of Dietary Supplements in Fitness Practitioners: A Cross-Sectional Observation Study
Massimiliano Mazzilli, Filippo Macaluso, S. de F. Zambelli, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 9, pp. 5005-5005
Open Access | Times Cited: 15
Massimiliano Mazzilli, Filippo Macaluso, S. de F. Zambelli, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 9, pp. 5005-5005
Open Access | Times Cited: 15
Impact of Herbal and Dietary Supplements Causing Drug‐Induced Liver Injury in Latin America
Vinícius Nunes, Nahúm Méndez‐Sánchez
Clinical Liver Disease (2020) Vol. 16, Iss. 3, pp. 83-86
Open Access | Times Cited: 16
Vinícius Nunes, Nahúm Méndez‐Sánchez
Clinical Liver Disease (2020) Vol. 16, Iss. 3, pp. 83-86
Open Access | Times Cited: 16
Versatility of Anabolic Androgenic Steroid–Induced Hepatotoxicity
Vaibhav Patil, Dinesh Jothimani, Kavya Harika, et al.
Journal of Clinical and Experimental Hepatology (2021) Vol. 12, Iss. 1, pp. 216-221
Open Access | Times Cited: 14
Vaibhav Patil, Dinesh Jothimani, Kavya Harika, et al.
Journal of Clinical and Experimental Hepatology (2021) Vol. 12, Iss. 1, pp. 216-221
Open Access | Times Cited: 14
Global Epidemiology of Drug-Induced Liver Injury (DILI)
Einar S. Björnsson
Current Hepatology Reports (2019) Vol. 18, Iss. 3, pp. 274-279
Closed Access | Times Cited: 15
Einar S. Björnsson
Current Hepatology Reports (2019) Vol. 18, Iss. 3, pp. 274-279
Closed Access | Times Cited: 15
Developmental and Inherited Liver Disease
Alberto Quaglia, Eve A. Roberts, Michael Torbenson
Elsevier eBooks (2023), pp. 122-294
Closed Access | Times Cited: 5
Alberto Quaglia, Eve A. Roberts, Michael Torbenson
Elsevier eBooks (2023), pp. 122-294
Closed Access | Times Cited: 5
Rare variant contribution to cholestatic liver disease in a South Asian population in the United Kingdom
Julia Zöllner, Sarah Finer, Kenneth J. Linton, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Julia Zöllner, Sarah Finer, Kenneth J. Linton, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Outcomes and Toxicology of Herbal Drugs in Alcoholic Hepatitis – A Single Center Experience from India
Cyriac Abby Philips, Sasidharan Rajesh, Tom George, et al.
Journal of Clinical and Translational Hepatology (2019) Vol. 7, Iss. X, pp. 1-12
Open Access | Times Cited: 11
Cyriac Abby Philips, Sasidharan Rajesh, Tom George, et al.
Journal of Clinical and Translational Hepatology (2019) Vol. 7, Iss. X, pp. 1-12
Open Access | Times Cited: 11
The scoop on brain health dietary supplement products containing huperzine A
Cindy Crawford, Yan‐Hong Wang, Bharathi Avula, et al.
Clinical Toxicology (2020) Vol. 58, Iss. 10, pp. 991-996
Closed Access | Times Cited: 11
Cindy Crawford, Yan‐Hong Wang, Bharathi Avula, et al.
Clinical Toxicology (2020) Vol. 58, Iss. 10, pp. 991-996
Closed Access | Times Cited: 11